ArticleResearch in nursing & health2026
Distinct Symptom Occurrence Subgroups Among Patients With Colorectal Cancer: Differences in Social Determinants of Health and Diet Quality.
Article in Research in nursing & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Colorectal cancer (CRC) is a leading cause of cancer mortality in the United States. Many patients with CRC experience physical and psychological symptoms that diminish quality of life and are shaped by social determinants of health (SDOH) and diet quality. This study aimed to (a) identify distinct symptom occurrence subgroups among patients with CRC, and (b) examine differences in SDOH characteristics and diet quality across these symptom occurrence subgroups. We conducted a secondary analysis of the ColoCare Study dataset from the Huntsman Cancer Institute, including CRC patients 6 months postdiagnosis. Latent class analysis identified subgroups based on the presence of symptoms. Chi-square tests and ANOVA examined subgroup differences in SDOH and diet quality, measured by the Healthy Eating Index (HEI)-2020. Logistic regression adjusted for cancer stage, comorbidity status, neoadjuvant or adjuvant therapy. Among 256 patients, three subgroups emerged: low (n = 84), moderate (n = 123), and high symptom occurrence (n = 49). Patients with high symptom occurrence were younger (F = 4.48, p = 0.01), more often Hispanic (χ² = 9.10, p = 0.01), had lower income (χ² = 12.92, p = 0.01), and more frequently received neoadjuvant therapy (χ² = 10.30, p = 0.006). They reported lower total social support (F = 5.60, p = 0.004) and poorer diet quality (F = 9.58, p = 0.0001). After adjustment, high symptom occurrence group had lower odds of adequate income (OR = 0.28, p = 0.0312), social support (OR = 0.886, p = 0.0100), and diet quality (OR = 0.94, p = 0.0156). Distinct CRC symptom profiles highlight the need for personalized dietary interventions and enhanced social support to improve symptom management. PATIENT OR PUBLIC CONTRIBUTION: Findings emphasize care strategies that address SDOH to optimize outcomes and quality of life for patients with CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.